【参考文献】
[1]Heijboer H, Brandjes D, Buller HR, et al. Deficiencies of coagulationinhibiting and fibrinolytic proteins in outpatients with deepvein thrombosis[J]. N EngI J Med,1990,323: 1512-1516.
[2]张广森. 凝血因子基因多态性与血栓形成[J]. 中华血液学杂志, 2000,21(9): 502-504.
[4]Lu P, Lu X, Xing RY,et al. Geneotype and allele frequency of the 27 bp tandem repeat polymorphism in the endothelial nitric oxide synthase gene in Chinese population[J]. Acta Genetica Sinica, 2001,28(12): 1093-1097.
[5]Wang XL,Sim AS,Badenhop RF,et al.A smokingdependent risk of coronary artery disease associated with a polymorphism of endothelial nitric oxide synthase gene[J].Nat Med,1996,2(1):41-45.
[6]Hingorani AD,Liang CF,Fatibene J,et al.A common variant of the endothelial nitric oside synthase(Glu298Asp) is a major risk factor for coronary artery disease in the UK[J]. Circulation, 1999, 100(14): 1515-1520.
[7]Shi YY, He L. SHEsis, a powerful software platform for analyses oflinkage disequilibrium, haplotype construction, and genetic association at polymorphism loci[J]. Cell Res,2005,15:97-98.
[9]Uwabo J, Soma M, Nakayama T et al. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese[J]. Am J Hypertension, 1998,11:125-128.
[10]Moncada S. The Largininenitric oxide pathway[J]. New Engl J Med,1993,329(27): 2002-2012.
[11]Marsden PA,Heng HH,Scherer SW,et al.Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene[J].J Biol Chem, 1993, 268(23):17478-17488.